ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹193 Cr | ₹-725 Cr | ₹-194 Cr | ₹19 Cr | ₹2,854 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-725 Cr |
Mar2022 | ₹-194 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹2,854 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-725 Cr | Negative | |
Mar2022 | ₹-194 Cr | Negative | |
Mar2021 | ₹19 Cr | -99.32 | |
Mar2020 | ₹2,854 Cr | - |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹95,010.4 Cr | -2% | -6.1% | 49.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -2% |
-6.1% |
49.9% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses